With expertise in Clinical Trials phase II, III und IV  Dr. Susan Feyerabend is the ideal contact person to Sponsors, Clinical Research Organisations and the Independant Review Board (IRB) helping to optimize the design of a study.

Frequently she is appointed "Head of the Clinical Trial" in Germany (German LKP) or asked to join Advisory Boards or Steering Committees of The Pharmaceutical Global Players